ArticleFrontiers in immunology2018

Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid-Results from the ToFingo Successor Study.

Lisa Lohmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.